| 1. |  4D Pharma plc Leeds, United Kingdom | Biotech | Preclinical to Phase II (at time of administration) | VIEW |
| 2. |  Acelot South San Francisco, California, USA | Biotech | Preclinical | VIEW |
| 3. |  Affitech Copenhagen, Denmark (with R&D in Oslo, Norway and San Francisco, USA) | Biotech | Clinical | VIEW |
| 4. |  Agostino Gemelli University Hospital Rome, Italy | CRO | Phase 1-4 | VIEW |
| 5. |  | CDMO | Commercial | VIEW |
| 6. |  All India Institute of Medical Sciences, Raipur Raipur, India | Diagnostics | Commercial | VIEW |
| 7. |  Almac Group Craigavon, United Kingdom | CDMO | Discovery | VIEW |
| 8. |  Altasciences Laval, Quebec, Canada | CRO | Preclinical to Phase II (early-phase development) | VIEW |
| 9. |  Amgen Thousand Oaks, California, United States | Pharma | Discovery through Commercial | VIEW |
| 10. |  Ami Organics Limited Surat, India | CDMO | Commercial | VIEW |
| 11. |  Anavex Life Sciences Corp. New York, United States | Biotech | Phase 2|Phase 3 | VIEW |
| 12. |  Anthem Biosciences Bangalore, India | CDMO | Commercial | VIEW |
| 13. |  AskGene Camarillo, California, United States | Biotech | Phase 3 | VIEW |
| 14. |  Aspen Pharmacare Holdings Limited uMhlanga, South Africa | Pharma | Commercial (Focus on post-patent branded generics rather than R&D pipeline) | VIEW |
| 15. |  Astellas Pharma Inc. Tokyo, Japan | Pharma | Discovery to Phase 3 | VIEW |
| 16. |  AstraZeneca Cambridge, United Kingdom | Pharma | Phase 1|Phase 2|Phase 3|Pre-registration|Commercial | VIEW |
| 17. |  Autolus Therapeutics London, United Kingdom | Biotech | Commercial + Phase 1/2 | VIEW |
| 18. |  | Pharma | Discovery through Commercial | VIEW |
| 19. |  BeOne Medicines (formerly BeiGene) Cambridge, Massachusetts, United States (corporate); Basel, Switzerland (post-redomiciliation May 2025) | Biotech | Phase 1-3 and Commercial | VIEW |
| 20. |  Becton Dickinson Franklin Lakes, New Jersey, USA | MedTech | Commercial | VIEW |
| 21. |  BenevolentAI London, United Kingdom | Biotech | Phase 1|Phase 2|Preclinical | VIEW |
| 22. |  Berg Health Framingham, Massachusetts, USA | Biotech | Phase 1/2 | VIEW |
| 23. |  BioMed Valley Discoveries Kansas City, Missouri, USA | Biotech | Clinical (Phase 1-2) | VIEW |
| 24. |  Biocon Limited Bengaluru, India | Pharma | Commercial, Phase 3, Phase 2, Phase 1 | VIEW |
| 25. |  Blanchard Valley Health System Findlay, USA | MedTech | Commercial | VIEW |
| 26. |  Boehringer Ingelheim Ingelheim am Rhein, Germany (near Mainz and Frankfurt) | Pharma | Phase 1|Phase 2|Phase 3|Commercial | VIEW |
| 27. |  Boston Institute of Biotechnology Southborough, USA | CDMO | Commercial | VIEW |
| 28. |  Bristol Myers Squibb Princeton, New Jersey, United States | Pharma | Phase 1-3 and Commercial | VIEW |
| 29. |  | Digital Health | Commercial | VIEW |
| 30. |  CDR-Life Schlieren, Zurich, Switzerland | Biotech | Phase 1 | VIEW |
| 31. |  CECOS University of Information Technology and Emerging Sciences Peshawar, Pakistan | Biotech | Preclinical | VIEW |
| 32. |  CEMKA Bourg-la-Reine, France | CRO | Commercial | VIEW |
| 33. |  CERNO Eeklo (Ghent region), Belgium | CRO | Commercial | VIEW |
| 34. |  CEVA Logistics Marseille, France | CRO | Commercial | VIEW |
| 35. |  CHUV (Centre Hospitalier Universitaire Vaudois) Lausanne, Switzerland | Biotech | Phase 3 | VIEW |
| 36. |  CMC Pharmaceuticals Solon, Ohio, USA | CDMO | Commercial | VIEW |
| 37. |  | Digital Health | Commercial | VIEW |
| 38. |  Cadence Design Systems San Jose, USA | Digital Health | Commercial | VIEW |
| 39. |  Calico Life Sciences South San Francisco, United States | Biotech | Phase 2 | VIEW |
| 40. |  Cambridge Consultants Cambridge, United Kingdom | MedTech | Commercial | VIEW |
| 41. |  | Biotech | Phase 1 - Phase 2 | VIEW |
| 42. |  | Digital Health | Commercial | VIEW |
| 43. |  Carelon Research Wilmington, Delaware, USA | CRO | Commercial | VIEW |
| 44. |  Celltrion Incheon, South Korea | Pharma | Commercial | VIEW |
| 45. |  Celularity Inc Florham Park, New Jersey, USA | Biotech | Phase 1/2 and Phase 2 | VIEW |
| 46. |  Cencora Conshohocken, Pennsylvania, United States | Pharma | Commercial (as distributor/logistics provider) | VIEW |
| 47. |  Centogene Rostock, Germany | Diagnostics | Preclinical | VIEW |
| 48. |  Cerbios-Pharma SA Barbengo-Lugano, Switzerland | CDMO | Preclinical|Clinical|Commercial | VIEW |
| 49. |  Cerebras Systems Sunnyvale, USA | Digital Health | Commercial | VIEW |
| 50. |  Chiba University Chiba, Japan | Biotech | Phase 2 | VIEW |
| 51. |  China Medical University Hospital (CMUH) Taichung, Taiwan | Biotech | Phase 2 | VIEW |
| 52. |  Chinese Medical Association Publishing House (CMAPH) Beijing, China | Digital Health | Commercial | VIEW |
| 53. |  Chugai Pharma Taiwan Ltd. Taipei, Taiwan | Pharma | Commercial | VIEW |
| 54. |  Chung-Ang University Seoul, South Korea | Biotech | Phase 3 | VIEW |
| 55. |  Cincinnati Children's Hospital Medical Center Cincinnati, USA | Biotech | Commercial | VIEW |
| 56. |  Circio Holding ASA Lysaker, Norway | Biotech | Phase 1/2 | VIEW |
| 57. |  City of Hope Duarte, California, USA | Biotech | Commercial | VIEW |
| 58. |  Clasp Therapeutics Rockville, Maryland, USA | Biotech | Phase 1 | VIEW |
| 59. |  Cliantha Research Ahmedabad, India | CRO | Commercial | VIEW |
| 60. |  Clinical Horizons Research Inc. Leonia, New Jersey, USA | CRO | Commercial | VIEW |
| 61. |  Compal Electronics, Inc. Taipei, Taiwan | MedTech | Phase 2 | VIEW |
| 62. |  Constructor Group Schaffhausen, Switzerland | Biotech | Preclinical | VIEW |
| 63. |  Crixmor LLC Malvern, Pennsylvania, USA | Biotech | Discovery | VIEW |
| 64. |  | Biotech | Phase 1 | VIEW |
| 65. |  Curadev Pharma Pvt Ltd Noida, India | Biotech | Phase 1 | VIEW |
| 66. |  Curasight Copenhagen, Denmark | Biotech | Phase 1-2 Clinical | VIEW |
| 67. |  Curatis Liestal, Switzerland | Biotech | Phase 3 | VIEW |
| 68. |  Curestack Tampa, Florida, USA | Digital Health | Commercial | VIEW |
| 69. |  Cuttsy+Cuttsy Cambridge, United Kingdom | CRO | N/A (Service Provider) | VIEW |
| 70. |  Cyborg Advisor New York, USA | Digital Health | Commercial | VIEW |
| 71. |  Cytel Cambridge, Massachusetts, USA | CRO | N/A - Service Provider | VIEW |
| 72. |  | CRO | Service Provider | VIEW |
| 73. |  Cytiva Marlborough, Massachusetts, USA | MedTech | Commercial | VIEW |
| 74. |  CytoAgents Pittsburgh, USA | Biotech | Phase 2 | VIEW |
| 75. |  CytoDyn Inc Vancouver, Washington | Biotech | Phase 2 clinical | VIEW |
| 76. |  CytoImmune Therapeutics Duarte, USA | Biotech | Phase 1 | VIEW |
| 77. |  CytoSen Therapeutics Orlando (Winter Springs), Florida, USA | Biotech | Phase 2 | VIEW |
| 78. |  CytoTools AG Heidelberg, Germany | Biotech | Phase 3 | VIEW |
| 79. |  CytoVac Hørsholm, Denmark | Biotech | Phase 2 | VIEW |
| 80. |  Cytocom, Inc. Fort Collins, Colorado, USA | Biotech | Phase 2/Phase 3 | VIEW |
| 81. |  CytomX Therapeutics, Inc. South San Francisco, California, United States | Biotech | Phase 1 (clinical), Preclinical (discovery collaborations) | VIEW |
| 82. |  Cytonus Therapeutics Carlsbad, California, United States | Biotech | Phase 1 | VIEW |
| 83. |  Cytorex Biosciences Weston, Florida, USA | Biotech | Preclinical | VIEW |
| 84. |  | Biotech | Phase I/II - Phase II | VIEW |
| 85. |  Cytovia Therapeutics Aventura, Florida, USA | Biotech | Phase 1/2 | VIEW |
| 86. |  Daiichi Sankyo Chuo, Tokyo, Japan | Pharma | Phase 1|Phase 2|Phase 3|Commercial | VIEW |
| 87. |  | CRO | Commercial | VIEW |
| 88. |  ELIQUENT Life Sciences Washington, DC, USA | CRO | Commercial | VIEW |
| 89. |  EY Global Delivery Services (GDS) London, United Kingdom | CRO | Late Stage | VIEW |
| 90. |  Eli Lilly and Company Indianapolis, Indiana, USA | Pharma | Phase 1-Phase 3 and Commercial | VIEW |
| 91. |  Ellipses Pharma London, United Kingdom | Biotech | Phase 1/2 | VIEW |
| 92. |  Evernorth Health Services St. Louis, USA | Digital Health | Commercial | VIEW |
| 93. |  Evinova Cambridge, United Kingdom (Regional offices in North America, Europe, and Asia-Pacific) | Digital Health | Commercial | VIEW |
| 94. |  Export-Import Bank of Korea Seoul, South Korea | Pharma | Commercial | VIEW |
| 95. |  | Pharma | Commercial | VIEW |
| 96. |  Flare Therapeutics Cambridge, MA, USA | Biotech | Phase 1-1B | VIEW |
| 97. |  Florence Healthcare Atlanta, USA | Digital Health | Commercial | VIEW |
| 98. |  Fosun Pharma Shanghai, China | Pharma | Commercial | VIEW |
| 99. |  Fusion Antibodies Belfast, Northern Ireland, United Kingdom | CRO | Discovery|Preclinical|Clinical (clients' projects) | VIEW |
| 100. |  Fusion Pharmaceuticals Inc. Hamilton, Ontario, Canada | Biotech | Phase 1|Phase 2|Phase 3 | VIEW |
| 101. |  GE HealthCare Chicago, USA (Global); Lindesnes/Oslo, Norway (PDx R&D/Manufacturing) | MedTech | Commercial | VIEW |
| 102. |  GSK plc London, United Kingdom | Pharma | Phase 1|Phase 2|Phase 3|Commercial | VIEW |
| 103. |  Genentech South San Francisco, California, United States | Biotech | Discovery through Commercial | VIEW |
| 104. |  HBM Partners Zug, Switzerland | Biotech | Commercial | VIEW |
| 105. |  | CRO | Commercial | VIEW |
| 106. |  HDS FormaciĂłn Barcelona, Spain | Digital Health | Commercial | VIEW |
| 107. |  Harvest Integrated Research Organization Shanghai, China | CRO | N/A - Service provider, not drug developer | VIEW |
| 108. |  Hemerion Therapeutics Villeneuve d'Ascq, France | Biotech | Phase 1/2 | VIEW |
| 109. |  Hone Bio Bristol, United Kingdom | Biotech | Preclinical | VIEW |
| 110. |  ICLOS-PDLC L'Hospitalet de Llobregat (Barcelona), Spain | CRO | N/A (Service Provider) | VIEW |
| 111. |  Immunomic Therapeutics, Inc. Rockville, Maryland, United States | Biotech | Phase 1 - Phase 2 | VIEW |
| 112. |  Infinitopes Oxford, United Kingdom | Biotech | Phase 1/IIa | VIEW |
| 113. |  Institut de Cancérologie de Lorraine Vandœuvre-lès-Nancy, France | Diagnostics | Clinical Care & Translational Research | VIEW |
| 114. |  Inttl Advocare New Delhi, India | CRO | Commercial | VIEW |
| 115. |  Istituto Oncologico Veneto (IOV) Padua, Italy | Diagnostics | Phase 3 | VIEW |
| 116. |  JOINN Laboratories Beijing, China | CRO | Commercial | VIEW |
| 117. |  Janux Therapeutics San Diego, California, USA | Biotech | Phase 1 | VIEW |
| 118. |  Johnson & Johnson New Brunswick, New Jersey, USA | Pharma | Discovery|Preclinical|Phase 1|Phase 2|Phase 3|Commercial | VIEW |
| 119. |  Kura Oncology Inc San Diego, California, USA | Biotech | Phase 1|Phase 2|Phase 3|Approved | VIEW |
| 120. |  Laboratoires Servier Orléans, France | Pharma | Preclinical through Commercial | VIEW |
| 121. |  Laboratorios BagĂł Buenos Aires, Argentina | Biotech | Commercial | VIEW |
| 122. |  Life Science Strategy Group Menlo Park, USA | CRO | Commercial | VIEW |
| 123. |  Lifespan (now Brown University Health) Providence, USA | Pharma | Commercial | VIEW |
| 124. |  MSD Rahway, New Jersey, USA | Pharma | Commercial | VIEW |
| 125. |  | Biotech | Commercial/Phase 3 | VIEW |
| 126. |  Medac Pharm / medac GmbH Wedel, Germany (near Hamburg) | Pharma | Commercial|Phase 2|Preclinical | VIEW |
| 127. |  Medical University of Silesia Katowice, Poland | Diagnostics | Commercial | VIEW |
| 128. |  Menarini Stemline New York, USA | Biotech | Commercial | VIEW |
| 129. |  Merck & Co., Inc. Rahway, New Jersey, United States | Pharma | Phase 1-Phase 3 and Commercial | VIEW |
| 130. |  N4 Pharma Chellaston, Derbyshire, United Kingdom | Biotech | Preclinical | VIEW |
| 131. |  NBE Therapeutics Basel, Switzerland | Biotech | Phase 1/2 | VIEW |
| 132. |  NPDK Bioconsulting San Diego, California | CRO | Commercial | VIEW |
| 133. |  Nanocan Therapeutics Corporation Princeton, New Jersey (also noted as National Harbor, MD) | Biotech | Phase I/II | VIEW |
| 134. |  Novartis Basel, Switzerland | Pharma | Phase 2, Phase 3, Commercial | VIEW |
| 135. |  Nutshell Therapeutics Shanghai, China (Pudong District, Building E, No. 1976 Middle Gaoke Road) | Biotech | Preclinical to Phase 1 | VIEW |
| 136. |  Nuvation Bio New York, United States | Biotech | Commercial | VIEW |
| 137. |  ONO PHARMA UK LTD London, United Kingdom | Pharma | Phase 1 through Commercial | VIEW |
| 138. |  ONO Pharmaceutical Osaka, Japan (Chuo-ku) | Pharma | Phase 1-Phase 3 | VIEW |
| 139. |  Oncotelic Therapeutics Agoura Hills, California, USA | Biotech | Phase 1|Phase 2|Phase 3 | VIEW |
| 140. |  Oracle Corporation Austin, Texas, USA | Pharma | Commercial | VIEW |
| 141. |  Otsuka Pharmaceutical Chiyoda, Tokyo, Japan | Pharma | Phase 1 through Commercial | VIEW |
| 142. |  Parexel Raleigh, North Carolina, USA | CRO | Phase I-IV (as a CRO, Parexel manages client pipelines, not its own) | VIEW |
| 143. |  Pfizer New York, United States | Pharma | Phase 1-3 and pending approval | VIEW |
| 144. |  Phanes Therapeutics San Diego, California, USA | Biotech | Phase 1/2 | VIEW |
| 145. |  Phanes Therapeutics, Inc. San Diego, California, USA | Biotech | Phase 1/2 | VIEW |
| 146. |  Philips Amsterdam, Netherlands | MedTech | Commercial | VIEW |
| 147. |  Pierre Fabre Group Castres, France | Pharma | Preclinical|Phase 1|Phase 2|Phase 3|Commercial | VIEW |
| 148. |  Policlinico Gemelli Rome, Italy | CRO | Commercial | VIEW |
| 149. |  Ribon Therapeutics Cambridge, MA, United States | Biotech | Phase 1/2 | VIEW |
| 150. |  Ridgeline Discovery Basel, Switzerland | Biotech | Discovery|Preclinical|Phase 1|Phase 2 | VIEW |
| 151. |  | Pharma | Discovery|Preclinical|Phase 1|Phase 2|Phase 3|Commercial | VIEW |
| 152. |  SSM Health St. Louis, United States | Digital Health | Commercial | VIEW |
| 153. |  | Pharma | Preclinical through Phase 3 | VIEW |
| 154. |  Scenic Biotech Amsterdam, The Netherlands | Biotech | Preclinical to IND-enabling | VIEW |
| 155. |  Senti Biosciences South San Francisco, California, USA | Biotech | Phase 1 | VIEW |
| 156. |  Sentinel Oncology Cambridge, United Kingdom | Biotech | Preclinical to Phase 1 | VIEW |
| 157. |  Shanghai Jeyou Pharmaceutical Co., Ltd. Shanghai, China (Pudong district) | Biotech | Preclinical to Phase 2 | VIEW |
| 158. |  Southern Taiwan University of Science and Technology (STUST) Tainan City, Taiwan | Biotech | Preclinical | VIEW |
| 159. |  | Biotech | Phase 1/Phase 2 | VIEW |
| 160. |  StemSynergy Therapeutics Miami, Florida, USA | Biotech | Preclinical and IND-enabling | VIEW |
| 161. |  Stemline Therapeutics, Inc. New York, United States | Biotech | Commercial + Clinical Development | VIEW |
| 162. |  Syneos Health Morrisville, North Carolina, USA | CRO | Not applicable - Syneos Health supports client pipelines across all stages (Discovery to Commercial) | VIEW |
| 163. |  TAE Life Sciences Irvine, California, United States | Biotech | Investigator Initiated Trials (IIT) - Early clinical stage | VIEW |
| 164. |  TVAX Biomedical, Inc. Lenexa, Kansas, United States | Biotech | Phase 2b/3 | VIEW |
| 165. |  TYG Oncology Mansfield, Nottinghamshire, United Kingdom | Biotech | Phase 1 | VIEW |
| 166. |  Takeda Pharmaceutical Company Tokyo, Japan | Pharma | Phase 3 | VIEW |
| 167. |  Thermo Fisher Scientific Waltham, Massachusetts, United States | CRO | Full spectrum - from drug discovery through Phase I-III and commercial | VIEW |
| 168. |  Tongji University Shanghai, China | Biotech | Phase 3 | VIEW |
| 169. |  Tvardi Therapeutics Inc Sugar Land/Houston, Texas, USA | Biotech | Phase 2 | VIEW |
| 170. |  UK Biobank Stockport, United Kingdom | Diagnostics | Commercial | VIEW |
| 171. |  Unicancer France (Federated across 20 hospital sites) | CRO | Phase 1 through Phase 4 (Clinical trials at all stages) | VIEW |
| 172. |  Universitas Indonesia Depok, Indonesia | CRO | Phase 3 | VIEW |
| 173. |  Universitas Sebelas Maret Surakarta, Indonesia | Diagnostics | Phase 2 | VIEW |
| 174. |  University of British Columbia Vancouver, Canada | Biotech | Discovery | VIEW |
| 175. |  University of California, Berkeley Berkeley, USA | Biotech | Discovery | VIEW |
| 176. |  University of Cincinnati Cincinnati, USA | Biotech | Commercial | VIEW |
| 177. |  University of Colorado Boulder Boulder, USA | Biotech | Discovery | VIEW |
| 178. |  University of Wisconsin–Madison Madison, USA | Biotech | Commercial | VIEW |
| 179. |  Vandalia Health Charleston, United States | MedTech | Commercial | VIEW |
| 180. |  Viatris Canonsburg, Pennsylvania, United States | Pharma | Phase 1 to Commercial | VIEW |
| 181. |  Yeditepe University Istanbul, Turkey | Biotech | Phase 3 | VIEW |
| 182. |  Yifan Pharmaceutical Co., Ltd. Hangzhou, China | Pharma | Phase 2-3, Commercial | VIEW |
| 183. |  Zydus Lifesciences Limited Ahmedabad, India | Pharma | Phase 1|Phase 2|Phase 3|Commercial | VIEW |
| 184. |  iRT Systems GmbH Koblenz, Germany | MedTech | Commercial | VIEW |